Skip to main content
Clinical Trials/NCT04180475
NCT04180475
Terminated
Not Applicable

Adherence to Medical Treatments for Telemedicine Patients

University of Virginia1 site in 1 country5 target enrollmentMay 30, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
University of Virginia
Enrollment
5
Locations
1
Primary Endpoint
Use of MedRem System
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

This study will test the feasibility of MedRem, a novel medication reminder and tracking system on wearable wrist devices, specifically with the Apple Watch 4. The study team will load the MedRem app onto two Apple Watch 4s for use during the study. As the device is placed on the wrist, it is free from the limitations of smartphones. However, one of the major challenges in developing interactive systems for wrist devices is their form factor. The touch screens available on these devices are tiny and much smaller compared to smart phones and tablet computers. MedRem enables user interactions by incorporating speech recognition and text-to-speech features along with clever interface design. The tiny display of the device is used for minimal inputs and outputs, while a user can retrieve and provide more information from/to the system through voice commands. Personalized models are built and updated over time to reduce errors in recognizing users' voice commands, and thus better user experience is provided.

Registry
clinicaltrials.gov
Start Date
May 30, 2019
End Date
January 25, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

John A Stankovic

Professor, Comp Science

University of Virginia

Eligibility Criteria

Inclusion Criteria

  • Phase 1 (Controls)
  • 18 - 75 years old
  • Good general health (self-reported), with no history of cerebral vascular accident (CVA)
  • English-speaking
  • Willingness and ability to comply with scheduled visits and study procedures
  • Phase 2 (Stroke Patients)
  • 18 - 75 years old
  • English-speaking
  • Willingness and ability to comply with scheduled visits and study procedures
  • Have requirements for home- based therapy regimens (i.e. physical/occupational therapy)

Exclusion Criteria

  • Phase 1 (Controls)
  • Pregnant women, fetuses, neonates, children, prisoners, cognitively impaired, non-English speaking subjects
  • Prohibitive cognitive impairments or language deficits
  • Does not have wireless internet connection at home
  • Phase 2 (Stroke Patients)
  • Pregnant women, fetuses, neonates, children, prisoners, cognitively impaired, non-English speaking subjects
  • Have a Modified Rankin Scale for Neurologic Disability (MDS) of 0-1 or 5
  • Prohibitive cognitive impairments or language deficits
  • Significant weakness, dystonia, or spasticity that will prevent proper use and response to the Apple Watch device
  • Live in nursing home or rehabilitation facility

Outcomes

Primary Outcomes

Use of MedRem System

Time Frame: 30 days

Assess the patients' adherence to medications and exercise. Adherence will be measured by patient responses to questions prompted by the MedRem System.

Assessment of Survey

Time Frame: 30 days

Acceptance and usability will be measured by the Intervention Patient MedRem Usability Survey. Steps were taken and distance covered data will also be collected from the Apple Watch.

Study Sites (1)

Loading locations...

Similar Trials